Immunocore case study
business forecasting in research and development
When it comes to budgeting in research and development leading T-cell receptor biotech company Immunocore needed to look beyond a simple cost centre model to forecast effectively..
CFO Ben Fryer needed both long and short views driven by people, projects and funding timelines. All of this was tricky to achieve in Excel, so Immunocore made the move to Adaptive Insights.
‘ADAPTIVE INSIGHTS DOES THE BREAD AND BUTTER STUFF BUT MORE EFFICIENTLY, SO THERE’S MORE TIME FOR UNDERSTANDING THE NUMBERS, WITH BETTER VISION OF ACTUALS AND MORE TIME TO PROVIDE A MEANINGFUL ANALYSIS"
Every research project had different structures, headcount, costs and timeframes which meant a suitable new model had to account for these. In addition, Immunocore was shifting their business model to develop their own drug portfolio taking them from research to market. Long and short term scenarios One of Ben’s requirements was to be able to combine a detailed short-term plan with high level long-term plan, the ability to switch between the two depending on scenario.